What is benralizumab? A Guide to the Biologic Medication
•
3 min read
First approved by the FDA in 2017, benralizumab is a biologic medication known as a monoclonal antibody. This targeted treatment is specifically used for certain severe inflammatory conditions, primarily severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA), that are driven by high levels of eosinophils in the body.
